(%)
Market is Open
Last quote from:
After-Hours Quote
Market is closed for
(%)
After-Hours Quote is Unavailable
Market is Open
Last quote from:
After-Hours Quote
Market is closed for
(%)
After-Hours Quote is Unavailable
- Ownership
-
Vertex Pharmaceuticals Incorporated Executive Compensation
* In original currency USD
Loading Data
|
Filing Date (SEC Report) |
Year | Reporting Name | Salary | Bonus | Stock Award | Incentive Plan Compensation | Other Compensation | Total Amount |
|---|---|---|---|---|---|---|---|---|
| Thursday, April 3rd, 2025 | 2024 | Nia Tatsis EVP Chief Regulatory and Quality Officer | 691,154 | 0 | 5,250,328 | 0 | 1,341,900 | 50,934 |
| Thursday, April 3rd, 2025 | 2023 | Reshma Kewalramani CEO and President | 1,500,000 | 0 | 15,001,894 | 0 | 4,050,000 | 42,547 |
| Thursday, April 3rd, 2025 | 2022 | Reshma Kewalramani CEO and President | 1,396,154 | 0 | 10,640,784 | 0 | 3,784,500 | 43,059 |
| Thursday, April 3rd, 2025 | 2024 | Reshma Kewalramani CEO and President | 1,541,154 | 0 | 15,002,202 | 0 | 4,941,600 | 53,712 |
| Thursday, April 3rd, 2025 | 2023 | Charles F. Wagner, Jr. EVP Chief Financial Officer | 825,000 | 0 | 5,250,552 | 0 | 1,256,063 | 40,136 |
| Thursday, April 3rd, 2025 | 2024 | Stuart A. Arbuckle EVP Chief Operating Officer | 941,154 | 0 | 6,234,857 | 0 | 2,130,000 | 77,452 |
| Thursday, April 3rd, 2025 | 2024 | David M. Altshuler EVP Chief Scientific Officer | 876,443 | 0 | 5,250,328 | 0 | 1,456,920 | 53,787 |
| Thursday, April 3rd, 2025 | 2023 | David M. Altshuler EVP Chief Scientific Officer | 825,000 | 0 | 4,375,089 | 0 | 1,299,375 | 41,636 |
| Thursday, April 3rd, 2025 | 2022 | David M. Altshuler EVP Chief Scientific Officer | 810,577 | 0 | 4,500,090 | 0 | 1,172,325 | 42,137 |
| Thursday, April 3rd, 2025 | 2022 | Stuart A. Arbuckle EVP Chief Operating Officer | 900,000 | 0 | 12,294,259 | 0 | 1,761,750 | 43,097 |
| Thursday, April 3rd, 2025 | 2024 | Charles F. Wagner, Jr. EVP Chief Financial Officer | 876,443 | 0 | 5,250,328 | 0 | 1,821,150 | 51,519 |
| Thursday, April 3rd, 2025 | 2023 | Stuart A. Arbuckle EVP Chief Operating Officer | 900,000 | 0 | 6,234,712 | 0 | 1,822,500 | 41,737 |
| Thursday, April 3rd, 2025 | 2022 | Charles F. Wagner, Jr. EVP Chief Financial Officer | 793,269 | 0 | 3,750,197 | 0 | 1,239,315 | 28,830 |
| Thursday, April 4th, 2024 | 2023 | Jeffrey M. Leiden Executive Chairman | 0 | 0 | 6,500,260 | 0 | 95,022 | 6,595,282 |
| Thursday, April 4th, 2024 | 2022 | Stuart A. Arbuckle EVP Chief Operating Officer | 900,000 | 0 | 12,294,259 | 1,761,750 | 43,097 | 14,999,106 |
| Thursday, April 4th, 2024 | 2023 | David M. Altshuler EVP Chief Scientific Officer | 825,000 | 0 | 4,375,089 | 1,299,375 | 41,636 | 6,541,100 |
| Thursday, April 4th, 2024 | 2022 | Reshma Kewalramani CEO and President | 1,396,154 | 0 | 10,640,784 | 3,784,500 | 43,059 | 15,864,497 |
| Thursday, April 4th, 2024 | 2023 | Reshma Kewalramani CEO and President | 1,500,000 | 0 | 15,001,894 | 4,050,000 | 42,547 | 20,594,441 |
| Thursday, April 4th, 2024 | 2022 | Jeffrey M. Leiden Executive Chairman | 0 | 0 | 8,500,250 | 0 | 92,930 | 8,593,180 |
| Thursday, April 4th, 2024 | 2022 | David M. Altshuler EVP Chief Scientific Officer | 810,577 | 0 | 4,500,090 | 1,172,325 | 42,137 | 6,525,129 |
| Thursday, April 4th, 2024 | 2023 | Charles F. Wagner, Jr. EVP Chief Financial Officer | 825,000 | 0 | 5,250,552 | 1,256,063 | 40,136 | 7,371,751 |
| Thursday, April 4th, 2024 | 2023 | Stuart A. Arbuckle EVP Chief Operating Officer | 900,000 | 0 | 6,234,712 | 1,822,500 | 41,737 | 8,998,949 |
| Thursday, April 4th, 2024 | 2022 | Charles F. Wagner, Jr. EVP Chief Financial Officer | 793,269 | 0 | 3,750,197 | 1,239,315 | 28,830 | 5,811,611 |
| Thursday, April 6th, 2023 | 2020 | Charles F. Wagner, Jr. EVP Chief Financial Officer | 726,923 | 0 | 4,375,585 | 946,680 | 41,202 | 6,090,390 |
| Thursday, April 6th, 2023 | 2022 | Jeffrey M. Leiden Executive Chairman | 0 | 0 | 8,500,250 | 0 | 92,930 | 8,593,180 |
| Thursday, April 6th, 2023 | 2021 | Jeffrey M. Leiden Executive Chairman | 242,308 | 0 | 7,875,259 | 0 | 39,672 | 8,157,239 |
| Thursday, April 6th, 2023 | 2020 | David M. Altshuler EVP Global Research and Chief Scientific Officer | 752,885 | 0 | 5,250,411 | 1,015,508 | 41,780 | 7,060,584 |
| Thursday, April 6th, 2023 | 2022 | David M. Altshuler EVP Global Research and Chief Scientific Officer | 810,577 | 0 | 4,500,090 | 1,172,325 | 42,137 | 6,525,129 |
| Thursday, April 6th, 2023 | 2020 | Stuart A. Arbuckle EVP Chief Operating Officer | 830,769 | 0 | 5,250,411 | 1,159,200 | 42,598 | 7,282,978 |
| Thursday, April 6th, 2023 | 2021 | Stuart A. Arbuckle EVP Chief Operating Officer | 842,308 | 0 | 5,250,173 | 1,676,700 | 40,960 | 7,810,141 |
| Thursday, April 6th, 2023 | 2021 | David M. Altshuler EVP Global Research and Chief Scientific Officer | 756,731 | 0 | 4,375,430 | 1,159,200 | 39,976 | 6,331,337 |
| Thursday, April 6th, 2023 | 2021 | Charles F. Wagner, Jr. EVP Chief Financial Officer | 729,615 | 0 | 4,375,430 | 1,078,539 | 40,348 | 6,223,932 |
| Thursday, April 6th, 2023 | 2020 | Jeffrey M. Leiden Executive Chairman | 1,121,539 | 0 | 13,335,168 | 1,973,400 | 43,138 | 16,473,245 |
| Thursday, April 6th, 2023 | 2022 | Stuart A. Arbuckle EVP Chief Operating Officer | 900,000 | 0 | 12,294,259 | 1,761,750 | 43,097 | 14,999,106 |
| Thursday, April 6th, 2023 | 2022 | Reshma Kewalramani CEO and President | 1,396,154 | 0 | 10,640,784 | 3,784,500 | 43,059 | 15,864,497 |
| Thursday, April 6th, 2023 | 2021 | Reshma Kewalramani CEO and President | 1,221,923 | 0 | 10,924,599 | 3,016,570 | 35,764 | 15,198,856 |
| Thursday, April 6th, 2023 | 2020 | Reshma Kewalramani CEO and President | 1,097,308 | 0 | 5,250,411 | 2,723,292 | 40,348 | 9,111,359 |
| Thursday, April 6th, 2023 | 2022 | Charles F. Wagner, Jr. EVP Chief Financial Officer | 793,269 | 0 | 3,750,197 | 1,239,315 | 28,830 | 5,811,611 |
| Thursday, April 7th, 2022 | 2021 | Stuart A. Arbuckle EVP Chief Operating Officer | 842,308 | 0 | 5,250,173 | 1,676,700 | 40,960 | 7,810,141 |
| Thursday, April 7th, 2022 | 2020 | Stuart A. Arbuckle EVP Chief Operating Officer | 830,769 | 0 | 5,250,411 | 1,159,200 | 42,598 | 7,282,978 |
| Thursday, April 7th, 2022 | 2021 | Charles F. Wagner, Jr. EVP Chief Financial Officer | 729,615 | 0 | 4,375,430 | 1,078,539 | 40,348 | 6,223,932 |
| Thursday, April 7th, 2022 | 2021 | Nia Tatsis EVP Chief Regulatory and Quality Officer | 550,000 | 0 | 5,250,173 | 743,820 | 40,035 | 6,584,028 |
| Thursday, April 7th, 2022 | 2019 | Stuart A. Arbuckle EVP Chief Operating Officer | 770,962 | 0 | 3,215,952 | 1,260,000 | 37,608 | 6,859,533 |
| Thursday, April 7th, 2022 | 2020 | Charles F. Wagner, Jr. EVP Chief Financial Officer | 726,923 | 0 | 4,375,585 | 946,680 | 41,202 | 6,090,390 |
| Thursday, April 7th, 2022 | 2020 | Jeffrey M. Leiden Executive Chairman | 1,121,539 | 0 | 13,335,168 | 1,973,400 | 43,138 | 16,473,245 |
| Thursday, April 7th, 2022 | 2020 | Reshma Kewalramani CEO and President | 1,097,308 | 0 | 5,250,411 | 2,723,292 | 40,348 | 9,111,359 |
| Thursday, April 7th, 2022 | 2021 | Reshma Kewalramani CEO and President | 1,221,923 | 0 | 10,924,599 | 3,016,570 | 35,764 | 15,198,856 |
| Thursday, April 7th, 2022 | 2019 | Reshma Kewalramani CEO and President | 702,308 | 0 | 3,215,952 | 1,260,000 | 63,665 | 6,816,936 |
| Thursday, April 7th, 2022 | 2021 | Jeffrey M. Leiden Executive Chairman | 242,308 | 0 | 7,875,259 | 0 | 39,672 | 8,157,239 |
| Thursday, April 7th, 2022 | 2019 | Jeffrey M. Leiden Executive Chairman | 1,300,000 | 0 | 9,334,681 | 3,510,000 | 73,265 | 18,789,985 |
| Thursday, April 7th, 2022 | 2019 | Charles F. Wagner, Jr. EVP Chief Financial Officer | 492,692 | 140,000 | 1,225,383 | 992,250 | 36,849 | 3,487,213 |
| Thursday, April 8th, 2021 | 2018 | Michael J. Parini (EVP Chief Administrative, Legal and Business Development Officer through March 1, 2021) | 746,923 | 0 | 2,625,244 | 823,384 | 29,000 | 5,372,336 |
| Thursday, April 8th, 2021 | 2020 | Jeffrey M. Leiden Executive Chairman (CEO and President through March 31, 2020) | 1,121,539 | 0 | 13,335,168 | 1,973,400 | 43,138 | 16,473,245 |
| Thursday, April 8th, 2021 | 2019 | Jeffrey M. Leiden Executive Chairman (CEO and President through March 31, 2020) | 1,300,000 | 0 | 9,334,681 | 3,510,000 | 73,265 | 18,789,985 |
| Thursday, April 8th, 2021 | 2018 | Jeffrey M. Leiden Executive Chairman (CEO and President through March 31, 2020) | 1,300,000 | 0 | 9,800,288 | 3,440,151 | 14,735 | 18,799,147 |
| Thursday, April 8th, 2021 | 2019 | Charles F. Wagner, Jr. EVP Chief Financial Officer | 492,692 | 140,000 | 1,225,383 | 992,250 | 36,849 | 3,487,213 |
| Thursday, April 8th, 2021 | 2019 | Michael J. Parini (EVP Chief Administrative, Legal and Business Development Officer through March 1, 2021) | 785,481 | 0 | 2,679,897 | 1,218,000 | 43,610 | 6,039,497 |
| Thursday, April 8th, 2021 | 2020 | Michael J. Parini (EVP Chief Administrative, Legal and Business Development Officer through March 1, 2021) | 830,769 | 0 | 4,375,585 | 1,081,920 | 67,404 | 6,355,678 |
| Thursday, April 8th, 2021 | 2020 | David Altshuler EVP Global Research and Chief Scientific Officer | 752,885 | 0 | 5,250,411 | 1,015,508 | 41,780 | 7,060,584 |
| Thursday, April 8th, 2021 | 2020 | Stuart A. Arbuckle EVP Chief Commercial and Operations Officer | 830,769 | 0 | 5,250,411 | 1,159,200 | 42,598 | 7,282,978 |
| Thursday, April 8th, 2021 | 2020 | Charles F. Wagner, Jr. EVP Chief Financial Officer | 726,923 | 0 | 4,375,585 | 946,680 | 41,202 | 6,090,390 |
| Thursday, April 8th, 2021 | 2019 | Stuart A. Arbuckle EVP Chief Commercial and Operations Officer | 770,962 | 0 | 3,215,952 | 1,260,000 | 37,608 | 6,859,533 |
| Thursday, April 8th, 2021 | 2020 | Reshma Kewalramani CEO and President (EVP Chief Medical Officer through March 31, 2020) | 1,097,308 | 0 | 5,250,411 | 2,723,292 | 40,348 | 9,111,359 |
| Thursday, April 8th, 2021 | 2019 | Reshma Kewalramani CEO and President (EVP Chief Medical Officer through March 31, 2020) | 702,308 | 0 | 3,215,952 | 1,260,000 | 63,665 | 6,816,936 |
| Thursday, April 8th, 2021 | 2018 | Stuart A. Arbuckle EVP Chief Commercial and Operations Officer | 721,923 | 0 | 2,625,244 | 824,175 | 38,965 | 5,347,092 |
| Tuesday, April 28th, 2020 | 2018 | Ian F. Smith Former EVP Chief Operating Officer and Former Interim Chief Financial Officer | 850,000 | 0 | 2,625,244 | 0 | 14,105 | 4,626,134 |
| Tuesday, April 28th, 2020 | 2019 | Stuart A. Arbuckle EVP Chief Commercial Officer | 770,962 | 0 | 3,215,952 | 1,260,000 | 37,608 | 6,859,533 |
| Tuesday, April 28th, 2020 | 2017 | Jeffrey M. Leiden Executive Chairman (CEO and President through March 31, 2020) | 1,300,000 | 0 | 8,750,114 | 3,463,200 | 13,110 | 17,227,301 |
| Tuesday, April 28th, 2020 | 2019 | Jeffrey M. Leiden Executive Chairman (CEO and President through March 31, 2020) | 1,300,000 | 0 | 9,334,681 | 3,510,000 | 73,265 | 18,789,985 |
| Tuesday, April 28th, 2020 | 2018 | Jeffrey M. Leiden Executive Chairman (CEO and President through March 31, 2020) | 1,300,000 | 0 | 9,800,288 | 3,440,151 | 14,735 | 18,799,147 |
| Tuesday, April 28th, 2020 | 2019 | Charles F. Wagner, Jr. | 492,692 | 140,000 | 1,225,383 | 992,250 | 36,849 | 3,487,213 |
| Tuesday, April 28th, 2020 | 2019 | Reshma Kewalramani CEO and President (EVP Chief Medical Officer through March , ) | 702,308 | 0 | 3,215,952 | 1,260,000 | 63,665 | 6,816,936 |
| Tuesday, April 28th, 2020 | 2018 | Amit Sachdev EVP Chief Patient Officer | 540,750 | 0 | 3,150,448 | 602,261 | 20,672 | 5,678,261 |
| Tuesday, April 28th, 2020 | 2017 | Amit Sachdev EVP Chief Patient Officer | 540,750 | 0 | 2,625,016 | 600,233 | 10,001 | 4,886,263 |
| Tuesday, April 28th, 2020 | 2019 | Amit Sachdev EVP Chief Patient Officer | 540,750 | 0 | 3,215,952 | 823,292 | 42,048 | 6,197,053 |
| Tuesday, April 28th, 2020 | 2019 | Paul M. Silva | 442,569 | 0 | 1,895,084 | 378,000 | 13,401 | 3,197,857 |
| Tuesday, April 28th, 2020 | 2018 | Stuart A. Arbuckle EVP Chief Commercial Officer | 721,923 | 0 | 2,625,244 | 824,175 | 38,965 | 5,347,092 |
| Tuesday, April 28th, 2020 | 2019 | Ian F. Smith Former EVP Chief Operating Officer and Former Interim Chief Financial Officer | 75,192 | 0 | 0 | 0 | 1,376,648 | 1,451,840 |
| Tuesday, April 28th, 2020 | 2017 | Ian F. Smith Former EVP Chief Operating Officer and Former Interim Chief Financial Officer | 848,077 | 0 | 2,625,016 | 1,339,770 | 13,110 | 5,936,236 |
| Tuesday, April 28th, 2020 | 2017 | Stuart A. Arbuckle EVP Chief Commercial Officer | 700,000 | 0 | 2,100,013 | 699,300 | 13,110 | 4,400,633 |
| Friday, April 26th, 2019 | 2017 | Amit Sachdev EVP Chief Regulatory Officer | 540,750 | 0 | 2,625,016 | 600,233 | 10,001 | 4,886,263 |
| Friday, April 26th, 2019 | 2016 | Ian F. Smith Former EVP Chief Operating and Interim Chief Financial Officer | 750,000 | 0 | 3,150,148 | 562,500 | 12,885 | 5,780,677 |
| Friday, April 26th, 2019 | 2016 | Stuart A. Arbuckle EVP Chief Commercial Officer | 672,885 | 0 | 3,150,148 | 420,000 | 12,885 | 5,561,062 |
| Friday, April 26th, 2019 | 2016 | Amit Sachdev EVP Chief Regulatory Officer | 540,750 | 0 | 3,150,148 | 438,007 | 960 | 5,435,009 |
| Friday, April 26th, 2019 | 2017 | Stuart A. Arbuckle EVP Chief Commercial Officer | 700,000 | 0 | 2,100,013 | 699,300 | 13,110 | 4,400,633 |
| Friday, April 26th, 2019 | 2018 | Michael Parini EVP Chief Legal and Administrative Officer | 746,923 | 0 | 2,625,244 | 834,384 | 29,000 | 5,372,336 |
| Friday, April 26th, 2019 | 2018 | Jeffrey Chodakewitz EVP Chief Medical Officer | 618,000 | 0 | 3,150,448 | 550,638 | 13,780 | 5,696,996 |
| Friday, April 26th, 2019 | 2016 | Jeffrey M. Leiden Chairman, President CEO | 1,300,000 | 0 | 9,800,076 | 2,246,400 | 12,885 | 17,419,758 |
| Friday, April 26th, 2019 | 2018 | Jeffrey M. Leiden Chairman, President CEO | 1,300,000 | 0 | 9,800,288 | 3,440,151 | 14,735 | 18,799,147 |
| Friday, April 26th, 2019 | 2017 | Jeffrey M. Leiden Chairman, President CEO | 1,300,000 | 0 | 8,750,114 | 3,463,200 | 13,110 | 17,227,301 |
| Friday, April 26th, 2019 | 2016 | Michael Parini EVP Chief Legal and Administrative Officer | 517,846 | 250,000 | 1,689,672 | 499,867 | 41,779 | 7,730,264 |
| Friday, April 26th, 2019 | 2018 | Stuart A. Arbuckle EVP Chief Commercial Officer | 721,923 | 0 | 2,625,244 | 824,175 | 38,965 | 5,347,092 |
| Friday, April 26th, 2019 | 2018 | Ian F. Smith Former EVP Chief Operating and Interim Chief Financial Officer | 850,000 | 0 | 2,625,244 | 0 | 14,105 | 4,626,134 |
| Friday, April 26th, 2019 | 2017 | Thomas Graney Former SVP Chief Financial Officer | 154,423 | 150,000 | 1,500,140 | 110,392 | 12,445 | 1,927,400 |
| Friday, April 26th, 2019 | 2018 | Thomas Graney Former SVP Chief Financial Officer | 550,000 | 0 | 1,400,130 | 367,538 | 13,685 | 2,937,685 |
| Friday, April 26th, 2019 | 2018 | Amit Sachdev EVP Chief Regulatory Officer | 540,750 | 0 | 3,150,448 | 602,261 | 20,672 | 5,678,261 |
| Friday, April 26th, 2019 | 2017 | Ian F. Smith Former EVP Chief Operating and Interim Chief Financial Officer | 848,077 | 0 | 2,625,016 | 1,339,770 | 13,110 | 5,936,236 |
| Friday, April 26th, 2019 | 2017 | Michael Parini EVP Chief Legal and Administrative Officer | 694,519 | 0 | 3,150,020 | 788,655 | 13,110 | 5,978,620 |
| Tuesday, April 17th, 2018 | 2015 | Ian F. Smith EVP Chief Operating Officer | 701,796 | 0 | 2,258,991 | 832,500 | 13,110 | 9,005,983 |
| Tuesday, April 17th, 2018 | 2016 | Ian F. Smith EVP Chief Operating Officer | 750,000 | 0 | 3,150,148 | 562,500 | 12,885 | 5,780,677 |
| Tuesday, April 17th, 2018 | 2017 | Jeffrey M. Leiden Chairman, President CEO | 1,300,000 | 0 | 8,750,114 | 3,463,200 | 13,110 | 17,227,301 |
| Tuesday, April 17th, 2018 | 2016 | Michael Parini EVP Chief Legal and Administrative Officer | 517,846 | 250,000 | 1,689,672 | 499,867 | 41,779 | 7,730,264 |
| Tuesday, April 17th, 2018 | 2017 | Michael Parini EVP Chief Legal and Administrative Officer | 694,519 | 0 | 3,150,020 | 788,655 | 13,110 | 5,978,620 |
| Tuesday, April 17th, 2018 | 2015 | Jeffrey M. Leiden Chairman, President CEO | 1,297,692 | 0 | 7,038,885 | 3,463,200 | 13,110 | 28,099,826 |
| Tuesday, April 17th, 2018 | 2016 | Jeffrey M. Leiden Chairman, President CEO | 1,300,000 | 0 | 9,800,076 | 2,246,400 | 12,885 | 17,419,758 |
| Tuesday, April 17th, 2018 | 2017 | David Altshuler EVP Chief Scientific Officer | 596,731 | 0 | 3,150,020 | 638,250 | 13,110 | 5,730,427 |
| Tuesday, April 17th, 2018 | 2016 | David Altshuler EVP Chief Scientific Officer | 561,442 | 0 | 2,625,152 | 500,250 | 12,885 | 4,787,349 |
| Tuesday, April 17th, 2018 | 2017 | Thomas Graney Former SVP Chief Financial Officer | 154,423 | 150,000 | 1,500,140 | 110,392 | 12,445 | 1,927,400 |
| Tuesday, April 17th, 2018 | 2016 | Amit Sachdev EVP Chief Regulatory Officer | 540,750 | 0 | 3,150,148 | 438,007 | 960 | 5,435,009 |
| Tuesday, April 17th, 2018 | 2015 | David Altshuler EVP Chief Scientific Officer | 528,846 | 250,000 | 9,078,750 | 552,628 | 13,110 | 12,387,868 |
| Tuesday, April 17th, 2018 | 2017 | Ian F. Smith EVP Chief Operating Officer | 848,077 | 0 | 2,625,016 | 1,339,770 | 13,110 | 5,936,236 |
| Tuesday, April 17th, 2018 | 2017 | Amit Sachdev EVP Chief Regulatory Officer | 540,750 | 0 | 2,625,016 | 600,233 | 10,001 | 4,886,263 |
| Friday, April 28th, 2017 | 2015 | Jeffrey M. Leiden Chairman, President CEO | 1,297,692 | 0 | 7,038,885 | 3,463,200 | 13,110 | 28,099,826 |
| Friday, April 28th, 2017 | 2015 | Stuart A. Arbuckle EVP Chief Commercial Officer | 629,262 | 0 | 2,258,991 | 721,500 | 13,110 | 8,822,449 |
| Friday, April 28th, 2017 | 2016 | Ian F. Smith EVP Chief Operating Officer and CFO | 750,000 | 0 | 3,150,148 | 562,500 | 12,885 | 5,780,677 |
| Friday, April 28th, 2017 | 2014 | Stuart A. Arbuckle EVP Chief Commercial Officer | 600,000 | 0 | 9,865,110 | 675,000 | 12,857 | 15,197,613 |
| Friday, April 28th, 2017 | 2016 | David Altshuler EVP Chief Scientific Officer | 561,442 | 0 | 2,625,152 | 500,250 | 12,885 | 4,787,349 |
| Friday, April 28th, 2017 | 2015 | Ian F. Smith EVP Chief Operating Officer and CFO | 701,796 | 0 | 2,258,991 | 832,500 | 13,110 | 9,005,983 |
| Friday, April 28th, 2017 | 2016 | Amit Sachdev EVP Chief Regulatory Officer | 540,750 | 0 | 3,150,148 | 438,007 | 960 | 5,435,009 |
| Friday, April 28th, 2017 | 2014 | Ian F. Smith EVP Chief Operating Officer and CFO | 650,000 | 0 | 9,865,110 | 731,250 | 12,857 | 15,303,863 |
| Friday, April 28th, 2017 | 2015 | David Altshuler EVP Chief Scientific Officer | 528,846 | 250,000 | 9,078,750 | 552,628 | 13,110 | 12,387,868 |
| Friday, April 28th, 2017 | 2016 | Michael Parini EVP Chief Legal and Administrative Officer | 517,846 | 250,000 | 1,689,672 | 499,867 | 41,779 | 7,730,264 |
| Friday, April 28th, 2017 | 2014 | Jeffrey M. Leiden Chairman, President CEO | 1,100,000 | 0 | 19,883,350 | 2,970,000 | 12,857 | 36,635,468 |
| Friday, April 28th, 2017 | 2016 | Stuart A. Arbuckle EVP Chief Commercial Officer | 672,885 | 0 | 3,150,148 | 420,000 | 12,885 | 5,561,062 |
| Friday, April 28th, 2017 | 2016 | Jeffrey M. Leiden Chairman, President CEO | 1,300,000 | 0 | 9,800,076 | 2,246,400 | 12,885 | 17,419,758 |
| Friday, April 29th, 2016 | 2015 | Ian F. Smith EVP Chief Financial Officer | 701,796 | 0 | 2,258,991 | 832,500 | 13,110 | 9,005,983 |
| Friday, April 29th, 2016 | 2015 | Jeffrey M. Leiden Chairman, President CEO | 1,297,692 | 0 | 7,038,885 | 3,463,200 | 13,110 | 28,099,826 |
| Friday, April 29th, 2016 | 2014 | Stuart A. Arbuckle EVP Chief Commercial Officer | 600,000 | 0 | 9,865,110 | 675,000 | 12,857 | 15,197,613 |
| Friday, April 29th, 2016 | 2015 | Jeffrey Chodakewitz EVP Chief Medical Officer | 615,231 | 0 | 1,882,493 | 617,382 | 15,254 | 7,830,416 |
| Friday, April 29th, 2016 | 2014 | Jeffrey M. Leiden Chairman, President CEO | 1,100,000 | 0 | 19,883,350 | 2,970,000 | 12,857 | 36,635,468 |
| Friday, April 29th, 2016 | 2015 | Stuart A. Arbuckle EVP Chief Commercial Officer | 629,262 | 0 | 2,258,991 | 721,500 | 13,110 | 8,822,449 |
| Friday, April 29th, 2016 | 2013 | Stuart A. Arbuckle EVP Chief Commercial Officer | 553,846 | 0 | 544,988 | 630,000 | 12,675 | 4,819,022 |
| Friday, April 29th, 2016 | 2013 | Jeffrey M. Leiden Chairman, President CEO | 1,038,462 | 0 | 1,773,963 | 2,772,000 | 12,675 | 13,126,474 |
| Friday, April 29th, 2016 | 2014 | Jeffrey Chodakewitz EVP Chief Medical Officer | 539,077 | 250,000 | 8,963,250 | 630,000 | 241,936 | 13,796,092 |
| Friday, April 29th, 2016 | 2013 | Ian F. Smith EVP Chief Financial Officer | 582,959 | 0 | 544,988 | 682,500 | 12,675 | 4,184,762 |
| Friday, April 29th, 2016 | 2014 | Ian F. Smith EVP Chief Financial Officer | 650,000 | 0 | 9,865,110 | 731,250 | 12,857 | 15,303,863 |
| Friday, April 29th, 2016 | 2015 | David Altshuler EVP Chief Scientific Officer | 528,846 | 250,000 | 9,078,750 | 552,628 | 13,110 | 12,387,868 |
| Thursday, April 30th, 2015 | 2012 | Stuart A. Arbuckle EVP Chief Commercial Officer | 169,615 | 365,000 | 2,131,308 | 117,600 | 293,482 | 4,808,697 |
| Thursday, April 30th, 2015 | 2014 | Ian F. Smith EVP Chief Financial Officer | 650,000 | 0 | 9,865,110 | 731,250 | 12,857 | 15,303,863 |
| Thursday, April 30th, 2015 | 2012 | Ian F. Smith EVP Chief Financial Officer | 539,241 | 0 | 457,379 | 376,577 | 12,450 | 3,109,193 |
| Thursday, April 30th, 2015 | 2013 | Stuart A. Arbuckle EVP Chief Commercial Officer | 553,846 | 0 | 544,988 | 630,000 | 12,675 | 4,819,022 |
| Thursday, April 30th, 2015 | 2013 | Jeffrey M. Leiden Chairman, President CEO | 1,038,462 | 0 | 1,773,963 | 2,772,000 | 12,675 | 13,126,474 |
| Thursday, April 30th, 2015 | 2014 | Jeffrey M. Leiden Chairman, President CEO | 1,100,000 | 0 | 19,883,350 | 2,970,000 | 12,857 | 36,635,468 |
| Thursday, April 30th, 2015 | 2014 | Stuart A. Arbuckle EVP Chief Commercial Officer | 600,000 | 0 | 9,865,110 | 675,000 | 12,857 | 15,197,613 |
| Thursday, April 30th, 2015 | 2014 | Jeffrey Chodakewitz EVP Chief Medical Officer | 539,077 | 250,000 | 8,963,250 | 630,000 | 241,936 | 13,796,092 |
| Thursday, April 30th, 2015 | 2014 | Kenneth L. Horton Former EVP Chief Legal Officer | 465,000 | 0 | 5,741,425 | 279,000 | 3,253 | 9,907,133 |
| Thursday, April 30th, 2015 | 2012 | Jeffrey M. Leiden Chairman, President CEO | 1,000,000 | 0 | 0 | 2,088,000 | 12,450 | 5,656,684 |
| Thursday, April 30th, 2015 | 2013 | Ian F. Smith EVP Chief Financial Officer | 582,959 | 0 | 544,988 | 682,500 | 12,675 | 4,184,762 |
| Thursday, April 30th, 2015 | 2012 | Kenneth L. Horton Former EVP Chief Legal Officer | 259,327 | 0 | 539,612 | 169,260 | 11,921 | 2,802,735 |
| Thursday, April 30th, 2015 | 2013 | Kenneth L. Horton Former EVP Chief Legal Officer | 465,000 | 0 | 544,988 | 439,425 | 12,625 | 4,539,551 |
| Friday, March 28th, 2014 | 2013 | Kenneth L. Horton EVP Chief Legal Officer | 465,000 | 0 | 544,988 | 439,425 | 12,625 | 4,539,551 |
| Friday, March 28th, 2014 | 2012 | Peter Mueller EVP, Global RD Chief Scientific Officer | 598,980 | 0 | 548,863 | 418,296 | 12,450 | 3,614,890 |
| Friday, March 28th, 2014 | 2011 | Peter Mueller EVP, Global RD Chief Scientific Officer | 581,534 | 0 | 562,494 | 525,146 | 12,495 | 3,937,612 |
| Friday, March 28th, 2014 | 2013 | Peter Mueller EVP, Global RD Chief Scientific Officer | 619,846 | 0 | 544,988 | 637,000 | 12,675 | 4,176,149 |
| Friday, March 28th, 2014 | 2012 | Stuart A. Arbuckle EVP Chief Commercial Officer | 169,615 | 365,000 | 2,131,308 | 117,600 | 293,482 | 4,808,697 |
| Friday, March 28th, 2014 | 2013 | Ian F. Smith EVP Chief Financial Officer | 582,959 | 0 | 544,988 | 682,500 | 12,675 | 4,184,762 |
| Friday, March 28th, 2014 | 2011 | Ian F. Smith EVP Chief Financial Officer | 523,535 | 0 | 468,738 | 425,493 | 12,495 | 3,344,580 |
| Friday, March 28th, 2014 | 2013 | Jeffrey M. Leiden Chairman, President CEO | 1,038,462 | 0 | 1,773,963 | 2,772,000 | 12,675 | 13,126,474 |
| Friday, March 28th, 2014 | 2012 | Ian F. Smith EVP Chief Financial Officer | 539,241 | 0 | 457,379 | 376,577 | 12,450 | 3,109,193 |
| Friday, March 28th, 2014 | 2011 | Jeffrey M. Leiden Chairman, President CEO | 50,000 | 0 | 3,497,678 | 0 | 92,441 | 10,717,661 |
| Friday, March 28th, 2014 | 2013 | Stuart A. Arbuckle EVP Chief Commercial Officer | 553,846 | 0 | 544,988 | 630,000 | 12,675 | 4,819,022 |
| Friday, March 28th, 2014 | 2012 | Jeffrey M. Leiden Chairman, President CEO | 1,000,000 | 0 | 0 | 2,088,000 | 12,450 | 5,656,684 |
| Friday, March 28th, 2014 | 2012 | Kenneth L. Horton EVP Chief Legal Officer | 259,327 | 0 | 539,612 | 169,260 | 11,921 | 2,802,735 |
| Thursday, April 4th, 2013 | 2010 | Matthew W. Emmens Former Chairman, President CEO | 1,129,192 | 0 | 1,842,727 | 2,931,638 | 9,829 | 14,912,160 |
| Thursday, April 4th, 2013 | 2012 | Kenneth L. Horton EVP Chief Legal Officer | 259,327 | 0 | 539,612 | 169,260 | 11,921 | 2,802,735 |
| Thursday, April 4th, 2013 | 2012 | David T. Howton, Jr. | 347,231 | 0 | 384,783 | 0 | 868,853 | 3,447,898 |
| Thursday, April 4th, 2013 | 2012 | Stuart A. Arbuckle EVP Chief Commercial Officer | 169,615 | 365,000 | 2,131,308 | 117,600 | 293,482 | 4,808,697 |
| Thursday, April 4th, 2013 | 2010 | Peter Mueller EVP, Global RD Chief Scientific Officer | 564,596 | 0 | 566,119 | 509,850 | 12,495 | 3,699,927 |
| Thursday, April 4th, 2013 | 2011 | Matthew W. Emmens Former Chairman, President CEO | 1,163,068 | 0 | 1,830,927 | 3,019,587 | 1,470 | 13,358,534 |
| Thursday, April 4th, 2013 | 2012 | Ian F. Smith EVP Chief Financial Officer | 539,241 | 0 | 457,379 | 376,577 | 12,450 | 3,109,193 |
| Thursday, April 4th, 2013 | 2012 | Matthew W. Emmens Former Chairman, President CEO | 467,514 | 0 | 1,786,558 | 0 | 29,667 | 6,896,029 |
| Thursday, April 4th, 2013 | 2011 | Ian F. Smith EVP Chief Financial Officer | 523,535 | 0 | 468,738 | 425,493 | 12,495 | 3,344,580 |
| Thursday, April 4th, 2013 | 2011 | Peter Mueller EVP, Global RD Chief Scientific Officer | 581,534 | 0 | 562,494 | 525,146 | 12,495 | 3,937,612 |
| Thursday, April 4th, 2013 | 2011 | Jeffrey M. Leiden Chairman, President CEO | 50,000 | 0 | 3,497,678 | 0 | 92,441 | 10,717,661 |
| Thursday, April 4th, 2013 | 2010 | Ian F. Smith EVP Chief Financial Officer | 491,220 | 0 | 471,759 | 459,000 | 12,429 | 3,122,481 |
| Thursday, April 4th, 2013 | 2012 | Jeffrey M. Leiden Chairman, President CEO | 1,000,000 | 0 | 0 | 2,088,000 | 12,450 | 5,656,684 |
| Thursday, April 4th, 2013 | 2012 | Peter Mueller EVP, Global RD Chief Scientific Officer | 598,980 | 0 | 548,863 | 418,296 | 12,450 | 3,614,890 |
| Tuesday, April 10th, 2012 | 2009 | Nancy J. Wysenski EVP Chief Commercial Officer | 31,846 | 25,000 | 793,800 | 0 | 32,028 | 10,178,214 |
| Tuesday, April 10th, 2012 | 2011 | Nancy J. Wysenski EVP Chief Commercial Officer | 503,004 | 0 | 468,738 | 454,230 | 12,477 | 3,352,768 |
| Tuesday, April 10th, 2012 | 2011 | Peter Mueller EVP, Global Research and Development, Chief Scientific | 581,534 | 0 | 562,494 | 525,146 | 12,495 | 3,937,612 |
| Tuesday, April 10th, 2012 | 2010 | Ian F. Smith EVP Chief Financial Officer | 491,220 | 0 | 471,759 | 459,000 | 12,429 | 3,122,481 |
| Tuesday, April 10th, 2012 | 2011 | Ian F. Smith EVP Chief Financial Officer | 523,535 | 0 | 468,738 | 425,493 | 12,495 | 3,344,580 |
| Tuesday, April 10th, 2012 | 2010 | Peter Mueller EVP, Global Research and Development, Chief Scientific | 564,596 | 0 | 566,119 | 509,850 | 12,495 | 3,699,927 |
| Tuesday, April 10th, 2012 | 2010 | Nancy J. Wysenski EVP Chief Commercial Officer | 474,192 | 0 | 0 | 426,300 | 35,097 | 1,547,282 |
| Tuesday, April 10th, 2012 | 2009 | Ian F. Smith EVP Chief Financial Officer | 479,250 | 0 | 405,297 | 403,245 | 12,405 | 9,104,036 |
| Tuesday, April 10th, 2012 | 2009 | Peter Mueller EVP, Global Research and Development, Chief Scientific | 538,029 | 0 | 405,297 | 495,000 | 12,421 | 9,254,586 |
| Tuesday, April 10th, 2012 | 2011 | Matthew W. Emmens Chair, President CEO | 1,163,068 | 0 | 1,830,927 | 3,019,587 | 1,470 | 13,358,534 |
| Tuesday, April 10th, 2012 | 2010 | Matthew W. Emmens Chair, President CEO | 1,129,192 | 0 | 1,842,727 | 2,931,638 | 9,829 | 14,912,160 |
| Tuesday, April 10th, 2012 | 2009 | Matthew W. Emmens Chair, President CEO | 1,002,693 | 0 | 4,498,687 | 2,846,251 | 231,121 | 19,278,158 |
| Tuesday, April 10th, 2012 | 2011 | Jeffrey M. Leiden Chairman, President CEO | 50,000 | 0 | 3,497,678 | 0 | 92,441 | 10,717,661 |
| Friday, April 8th, 2011 | 2008 | Peter Mueller Executive Vice President, Global Research and | 456,664 | 0 | 274,359 | 385,324 | 11,563 | 2,974,464 |
| Friday, April 8th, 2011 | 2010 | Matthew W. Emmens Chairman, President and | 1,129,192 | 0 | 1,842,727 | 2,931,638 | 9,829 | 14,912,160 |
| Friday, April 8th, 2011 | 2009 | Matthew W. Emmens Chairman, President and | 1,002,693 | 0 | 4,498,687 | 2,846,251 | 231,121 | 19,278,158 |
| Friday, April 8th, 2011 | 2010 | Kenneth S. Boger Senior Vice President and Chief Legal Officer | 435,175 | 0 | 396,881 | 342,563 | 12,338 | 2,607,267 |
| Friday, April 8th, 2011 | 2009 | Kenneth S. Boger Senior Vice President and Chief Legal Officer | 426,214 | 0 | 340,968 | 324,613 | 12,316 | 3,161,083 |
| Friday, April 8th, 2011 | 2008 | Kenneth S. Boger Senior Vice President and Chief Legal Officer | 398,408 | 0 | 153,876 | 315,158 | 11,543 | 1,915,470 |
| Friday, April 8th, 2011 | 2009 | Ian F. Smith Executive Vice President and Chief Financial Officer | 479,250 | 0 | 405,297 | 403,245 | 12,405 | 9,104,036 |
| Friday, April 8th, 2011 | 2008 | Ian F. Smith Executive Vice President and Chief Financial Officer | 444,234 | 0 | 182,900 | 391,500 | 11,804 | 2,262,326 |
| Friday, April 8th, 2011 | 2010 | Peter Mueller Executive Vice President, Global Research and | 564,596 | 0 | 566,119 | 509,850 | 12,495 | 3,699,927 |
| Friday, April 8th, 2011 | 2010 | Amit Sachdev Senior Vice President, | 380,241 | 0 | 396,881 | 304,500 | 1,229 | 2,503,161 |
| Friday, April 8th, 2011 | 2009 | Amit Sachdev Senior Vice President, | 378,341 | 0 | 409,188 | 278,547 | 1,210 | 4,029,657 |
| Friday, April 8th, 2011 | 2010 | Ian F. Smith Executive Vice President and Chief Financial Officer | 491,220 | 0 | 471,759 | 459,000 | 12,429 | 3,122,481 |
| Friday, April 8th, 2011 | 2009 | Peter Mueller Executive Vice President, Global Research and | 538,029 | 0 | 405,297 | 495,000 | 12,421 | 9,254,586 |
| Thursday, April 15th, 2010 | 2008 | Joshua Boger, Ph.D. Former President and Chief Executive Officer | 708,539 | 0 | 595,356 | 978,750 | 11,835 | 6,304,485 |
| Thursday, April 15th, 2010 | 2007 | Ian F. Smith Executive Vice President and Chief Financial Officer | 411,595 | 0 | 1,164,328 | 141,907 | 12,543 | 3,372,273 |
| Thursday, April 15th, 2010 | 2008 | Ian F. Smith Executive Vice President and Chief Financial Officer | 444,234 | 0 | 182,900 | 391,500 | 11,804 | 2,262,326 |
| Thursday, April 15th, 2010 | 2009 | Ian F. Smith Executive Vice President and Chief Financial Officer | 479,250 | 0 | 405,297 | 403,245 | 12,405 | 9,104,036 |
| Thursday, April 15th, 2010 | 2009 | Matthew W. Emmens Chairman, President and Chief Executive Officer | 1,002,693 | 0 | 4,498,687 | 2,846,251 | 231,121 | 19,278,158 |
| Thursday, April 15th, 2010 | 2007 | Joshua Boger, Ph.D. Former President and Chief Executive Officer | 616,615 | 0 | 1,427,431 | 318,888 | 12,852 | 7,720,455 |
| Thursday, April 15th, 2010 | 2009 | Joshua Boger, Ph.D. Former President and Chief Executive Officer | 373,410 | 0 | 1,583,122 | 0 | 3,038,631 | 10,148,369 |
| Thursday, April 15th, 2010 | 2009 | Amit Sachdev EVP Chief Regulatory Officer | 378,341 | 0 | 409,188 | 278,547 | 1,210 | 4,029,657 |
| Thursday, April 15th, 2010 | 2009 | Nancy J. Wysenski Executive Vice President and Chief Commercial Officer | 31,846 | 25,000 | 793,800 | 0 | 32,028 | 10,178,214 |
| Thursday, April 15th, 2010 | 2007 | Peter Mueller, Ph.D. Executive Vice President, Global Research and Development, and Chief Scientific Officer | 444,361 | 0 | 1,164,328 | 229,804 | 12,712 | 3,493,105 |
| Thursday, April 15th, 2010 | 2008 | Peter Mueller, Ph.D. Executive Vice President, Global Research and Development, and Chief Scientific Officer | 456,664 | 0 | 274,359 | 385,324 | 11,563 | 2,974,464 |
| Thursday, April 15th, 2010 | 2009 | Peter Mueller, Ph.D. Executive Vice President, Global Research and Development, and Chief Scientific Officer | 538,029 | 0 | 405,297 | 495,000 | 12,421 | 9,254,586 |
| Wednesday, April 8th, 2009 | 2006 | Joshua S. Boger, Ph.D. Chief Executive Officer | 593,921 | 0 | 579,222 | 705,600 | 11,376 | 5,922,958 |
| Wednesday, April 8th, 2009 | 2008 | Joshua S. Boger, Ph.D. Chief Executive Officer | 708,539 | 0 | 959,862 | 978,750 | 11,835 | 8,547,420 |
| Wednesday, April 8th, 2009 | 2008 | Kenneth S. Boger, M.B.A., J.D. Senior Vice President and General Counsel | 398,408 | 0 | 335,789 | 315,158 | 11,543 | 2,193,813 |
| Wednesday, April 8th, 2009 | 2007 | Kenneth S. Boger, M.B.A., J.D. Senior Vice President and General Counsel | 387,675 | 0 | 580,922 | 116,952 | 12,415 | 2,111,174 |
| Wednesday, April 8th, 2009 | 2006 | Kenneth S. Boger, M.B.A., J.D. Senior Vice President and General Counsel | 374,668 | 0 | 209,889 | 258,778 | 11,277 | 1,698,103 |
| Wednesday, April 8th, 2009 | 2008 | Ian F. Smith Executive Vice President and Chief Financial Officer | 444,234 | 0 | 590,411 | 391,500 | 11,804 | 2,703,819 |
| Wednesday, April 8th, 2009 | 2007 | Ian F. Smith Executive Vice President and Chief Financial Officer | 411,595 | 0 | 745,138 | 141,907 | 12,543 | 2,451,821 |
| Wednesday, April 8th, 2009 | 2008 | Peter Mueller, Ph.D. Executive Vice President, Drug Innovation and Realization, and Chief Scientific Officer | 456,664 | 0 | 618,252 | 385,324 | 11,563 | 3,113,864 |
| Wednesday, April 8th, 2009 | 2007 | Kurt C. Graves Executive Vice President, Chief Commercial Officer and Head, Strategic Development | 197,308 | 250,000 | 177,221 | 104,490 | 388,313 | 1,285,890 |
| Wednesday, April 8th, 2009 | 2008 | Kurt C. Graves Executive Vice President, Chief Commercial Officer and Head, Strategic Development | 455,712 | 0 | 453,051 | 369,968 | 11,700 | 2,073,457 |
| Wednesday, April 8th, 2009 | 2007 | Peter Mueller, Ph.D. Executive Vice President, Drug Innovation and Realization, and Chief Scientific Officer | 444,361 | 0 | 747,601 | 229,804 | 12,712 | 2,878,750 |
| Wednesday, April 8th, 2009 | 2006 | Peter Mueller, Ph.D. Executive Vice President, Drug Innovation and Realization, and Chief Scientific Officer | 429,452 | 0 | 212,297 | 338,991 | 11,343 | 1,982,518 |
| Wednesday, April 8th, 2009 | 2006 | Ian F. Smith Executive Vice President and Chief Financial Officer | 395,830 | 0 | 209,889 | 313,995 | 11,291 | 1,914,697 |
| Wednesday, April 8th, 2009 | 2007 | Joshua S. Boger, Ph.D. Chief Executive Officer | 616,615 | 0 | 1,943,077 | 318,888 | 12,852 | 8,211,760 |
| Friday, March 31st, 2006 | 2005 | Ian F. Smith Executive Vice President and Chief Financial Officer | 358,310 | 223,200 | 60,249 | 0 | 9,450 | 651,209 |
| Friday, March 31st, 2006 | 2005 | Joshua S. Boger Chairman, President and Chief Executive Officer | 544,744 | 492,590 | 175,726 | 0 | 9,450 | 1,222,510 |
| Friday, March 31st, 2006 | 2003 | Peter Mueller Executive Vice President, Drug Innovation and Realization and | 171,635 | 50,000 | 17,683 | 0 | 0 | 239,318 |
| Friday, March 31st, 2006 | 2005 | Peter Mueller Executive Vice President, Drug Innovation and Realization and | 404,190 | 252,310 | 76,104 | 0 | 9,450 | 742,054 |
| Friday, March 31st, 2006 | 2003 | Victor Hartmann Executive Vice President, Strategic and Corporate | 0 | 0 | 0 | 0 | 0 | 0 |
| Friday, March 31st, 2006 | 2004 | Victor Hartmann Executive Vice President, Strategic and Corporate | 0 | 0 | 0 | 0 | 0 | 0 |
| Friday, March 31st, 2006 | 2004 | Joshua S. Boger Chairman, President and Chief Executive Officer | 525,006 | 242,550 | 935,500 | 0 | 9,363 | 1,712,419 |
| Friday, March 31st, 2006 | 2005 | Victor Hartmann Executive Vice President, Strategic and Corporate | 369,600 | 386,460 | 800,100 | 0 | 9,450 | 1,565,610 |
| Friday, March 31st, 2006 | 2003 | Joshua S. Boger Chairman, President and Chief Executive Officer | 525,006 | 0 | 51,576 | 0 | 8,452 | 585,034 |
| Friday, March 31st, 2006 | 2004 | Kenneth S. Boger Senior Vice President and General Counsel | 338,647 | 112,390 | 579,150 | 0 | 9,225 | 1,039,412 |
| Friday, March 31st, 2006 | 2004 | Peter Mueller Executive Vice President, Drug Innovation and Realization and | 381,164 | 210,660 | 597,390 | 0 | 9,225 | 1,198,439 |
| Friday, March 31st, 2006 | 2003 | Kenneth S. Boger Senior Vice President and General Counsel | 332,257 | 0 | 17,683 | 0 | 9,000 | 358,940 |
| Friday, March 31st, 2006 | 2005 | Kenneth S. Boger Senior Vice President and General Counsel | 353,368 | 220,124 | 60,249 | 0 | 9,450 | 643,191 |
| Friday, March 31st, 2006 | 2003 | Ian F. Smith Executive Vice President and Chief Financial Officer | 317,521 | 42,184 | 17,683 | 0 | 10,331 | 387,719 |
| Friday, March 31st, 2006 | 2004 | Ian F. Smith Executive Vice President and Chief Financial Officer | 341,986 | 113,960 | 606,510 | 0 | 9,225 | 1,071,681 |
| Tuesday, March 29th, 2005 | 2004 | Peter Mueller Chief Scientific Officer and Senior Vice President, Drug Discovery and Innovation | 381,164 | 210,660 | 597,390 | 0 | 14,844 | 1,204,058 |
| Tuesday, March 29th, 2005 | 2003 | Peter Mueller Chief Scientific Officer and Senior Vice President, Drug Discovery and Innovation | 171,635 | 50,000 | 17,683 | 0 | 0 | 239,318 |
| Tuesday, March 29th, 2005 | 2002 | Peter Mueller Chief Scientific Officer and Senior Vice President, Drug Discovery and Innovation | 0 | 0 | 0 | 0 | 0 | 0 |
| Tuesday, March 29th, 2005 | 2004 | N. Anthony Coles Senior Vice President, Commercial Operations | 364,657 | 121,350 | 597,390 | 0 | 8,750 | 1,092,147 |
| Tuesday, March 29th, 2005 | 2003 | N. Anthony Coles Senior Vice President, Commercial Operations | 340,152 | 0 | 17,683 | 0 | 9,000 | 366,835 |
| Tuesday, March 29th, 2005 | 2002 | N. Anthony Coles Senior Vice President, Commercial Operations | 250,000 | 155,440 | 0 | 0 | 8,857 | 414,297 |
| Tuesday, March 29th, 2005 | 2004 | Ian F. Smith Senior Vice President and Chief Financial Officer | 341,986 | 113,960 | 606,510 | 0 | 9,225 | 1,071,681 |
| Tuesday, March 29th, 2005 | 2004 | Joshua S. Boger Chairman and Chief Executive Officer | 525,006 | 242,550 | 935,500 | 0 | 9,363 | 1,712,419 |
| Tuesday, March 29th, 2005 | 2003 | Joshua S. Boger Chairman and Chief Executive Officer | 525,006 | 0 | 51,576 | 0 | 8,452 | 585,034 |
| Tuesday, March 29th, 2005 | 2002 | Joshua S. Boger Chairman and Chief Executive Officer | 509,622 | 175,000 | 0 | 0 | 9,775 | 694,397 |
| Tuesday, March 29th, 2005 | 2004 | Vicki L. Sato President | 441,004 | 203,740 | 779,625 | 0 | 9,225 | 1,433,594 |
| Tuesday, March 29th, 2005 | 2003 | Ian F. Smith Senior Vice President and Chief Financial Officer | 317,521 | 42,184 | 17,683 | 0 | 10,331 | 387,719 |
| Tuesday, March 29th, 2005 | 2002 | Ian F. Smith Senior Vice President and Chief Financial Officer | 305,863 | 110,020 | 0 | 0 | 5,997 | 421,880 |
| Tuesday, March 29th, 2005 | 2003 | Vicki L. Sato President | 441,004 | 0 | 36,840 | 0 | 9,000 | 486,844 |
| Tuesday, March 29th, 2005 | 2002 | Vicki L. Sato President | 428,081 | 147,000 | 0 | 0 | 8,835 | 583,916 |
| Thursday, March 25th, 2004 | 2001 | John J. Alam Senior Vice President, Drug Evaluation and Approval | 256,958 | 32,120 | 0 | 0 | 7,650 | 296,728 |
| Thursday, March 25th, 2004 | 2003 | John J. Alam Senior Vice President, Drug Evaluation and Approval | 304,471 | 80,325 | 0 | 0 | 9,906 | 394,702 |
| Thursday, March 25th, 2004 | 2001 | Vicki L. Sato President | 400,010 | 100,000 | 0 | 0 | 7,650 | 507,660 |
| Thursday, March 25th, 2004 | 2002 | Vicki L. Sato President | 428,081 | 147,000 | 17,683 | 0 | 8,835 | 601,599 |
| Thursday, March 25th, 2004 | 2003 | Vicki L. Sato President | 441,004 | 0 | 17,683 | 0 | 9,000 | 467,687 |
| Thursday, March 25th, 2004 | 2001 | Joshua S. Boger Chairman and Chief Executive Officer | 474,994 | 150,000 | 17,683 | 0 | 7,650 | 650,327 |
| Thursday, March 25th, 2004 | 2002 | Joshua S. Boger Chairman and Chief Executive Officer | 509,622 | 175,000 | 36,840 | 0 | 9,775 | 731,237 |
| Thursday, March 25th, 2004 | 2003 | Joshua S. Boger Chairman and Chief Executive Officer | 525,006 | 0 | 51,576 | 0 | 8,452 | 585,034 |
| Thursday, March 25th, 2004 | 2002 | N. Anthony Coles Senior Vice President, Commercial Operations Pharmaceutical Products | 250,000 | 155,440 | 0 | 0 | 8,857 | 414,297 |
| Thursday, March 25th, 2004 | 2001 | Ian F. Smith Senior Vice President and Chief Financial Officer | 47,309 | 100,000 | 0 | 0 | 0 | 147,309 |
| Thursday, March 25th, 2004 | 2002 | Ian F. Smith Senior Vice President and Chief Financial Officer | 305,863 | 110,020 | 0 | 0 | 5,997 | 421,880 |
| Thursday, March 25th, 2004 | 2003 | Ian F. Smith Senior Vice President and Chief Financial Officer | 317,521 | 42,184 | 0 | 0 | 10,331 | 370,036 |
| Thursday, March 25th, 2004 | 2001 | N. Anthony Coles Senior Vice President, Commercial Operations Pharmaceutical Products | 0 | 0 | 0 | 0 | 0 | 0 |
| Thursday, March 25th, 2004 | 2003 | N. Anthony Coles Senior Vice President, Commercial Operations Pharmaceutical Products | 340,152 | 0 | 0 | 0 | 9,000 | 349,152 |
| Thursday, March 25th, 2004 | 2002 | John J. Alam Senior Vice President, Drug Evaluation and Approval | 285,485 | 126,040 | 0 | 0 | 9,463 | 420,988 |
| Wednesday, April 9th, 2003 | 2001 | John J. Alam Senior Vice President, Drug Evaluation and Approval | 256,958 | 32,120 | 0 | 0 | 7,650 | 296,728 |
| Wednesday, April 9th, 2003 | 2000 | Vicki L. Sato President | 332,124 | 150,000 | 0 | 0 | 7,291 | 489,415 |
| Wednesday, April 9th, 2003 | 2001 | Vicki L. Sato President | 400,010 | 100,000 | 0 | 0 | 7,650 | 507,660 |
| Wednesday, April 9th, 2003 | 2002 | Vicki L. Sato President | 428,081 | 147,000 | 0 | 0 | 8,835 | 583,916 |
| Wednesday, April 9th, 2003 | 2000 | Joshua S. Boger Chairman and Chief Executive Officer | 407,134 | 250,000 | 0 | 0 | 21,196 | 678,330 |
| Wednesday, April 9th, 2003 | 2002 | John J. Alam Senior Vice President, Drug Evaluation and Approval | 285,485 | 126,040 | 0 | 0 | 9,463 | 420,988 |
| Wednesday, April 9th, 2003 | 2001 | N. Anthony Coles Senior Vice President, Commercial Operations Pharmaceutical Products | 0 | 0 | 0 | 0 | 0 | 0 |
| Wednesday, April 9th, 2003 | 2002 | N. Anthony Coles Senior Vice President, Commercial Operations Pharmaceutical Products | 250,000 | 155,440 | 0 | 0 | 8,857 | 414,297 |
| Wednesday, April 9th, 2003 | 2000 | John J. Alam Senior Vice President, Drug Evaluation and Approval | 229,424 | 45,884 | 0 | 0 | 7,403 | 282,711 |
| Wednesday, April 9th, 2003 | 2000 | N. Anthony Coles Senior Vice President, Commercial Operations Pharmaceutical Products | 0 | 0 | 0 | 0 | 0 | 0 |
| Wednesday, April 9th, 2003 | 2002 | Ian F. Smith Vice President and Chief Financial Officer | 305,863 | 110,020 | 0 | 0 | 5,997 | 421,880 |
| Wednesday, April 9th, 2003 | 2001 | Ian F. Smith Vice President and Chief Financial Officer | 47,309 | 100,000 | 0 | 0 | 0 | 147,309 |
| Wednesday, April 9th, 2003 | 2000 | Ian F. Smith Vice President and Chief Financial Officer | 0 | 0 | 0 | 0 | 0 | 0 |
| Wednesday, April 9th, 2003 | 2002 | Joshua S. Boger Chairman and Chief Executive Officer | 509,622 | 175,000 | 0 | 0 | 9,775 | 694,397 |
| Wednesday, April 9th, 2003 | 2001 | Joshua S. Boger Chairman and Chief Executive Officer | 474,994 | 150,000 | 0 | 0 | 7,650 | 632,644 |
